Flutoprazepam (CAS 25967-29-7) Anxiolytic Pharmaceutical API

Flutoprazepam (CAS 25967-29-7) is a long-acting benzodiazepine anxiolytic API, acclaimed for its sustained efficacy in alleviating anxiety, relieving nervous tension, and improving sleep quality. Its optimized molecular structure enhances binding affinity to central GABA receptors, delivering prolonged inhibitory effects on overactive neuronal activity—ensuring steady anxiety control without frequent dosing. This high-purity pharmaceutical raw material complies with international pharmacopoeial standards, guaranteeing consistent potency and stability for clinical formulation.

Designed for pharmaceutical manufacturers, it is a core ingredient for formulating oral medications targeting generalized anxiety disorder, persistent nervousness, and anxiety-associated insomnia. Valued for its long half-life and minimal adverse reactions, it addresses the demand for convenient, reliable anxiety management solutions in clinical practice. Choose this premium anxiolytic API to develop high-quality formulations that enhance patients’ mental comfort and sleep continuity.